IQVIA Holdings Inc. (iqv)
IQV Estimates
Public analyst price targets and consensus snapshot for IQVIA Holdings Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $267.86 |
| Analyst mean target | $277.94 |
| Analyst high target | $300.00 |
| Analyst low target | $247.00 |
| Upside vs mean target | 3.8% |
| Consensus recommendation | Strong Buy |
| Number of analysts | 18 |
| Forward P/E | 18.52 |
Start Free — open IQV in Vest Terminal
Access live data, filings, ownership, and analysis for IQVIA Holdings Inc..
IQVIA Holdings Inc. FAQ
What does IQVIA Holdings Inc. (IQV) do?
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, R…
What is IQV's P/E ratio?
IQVIA Holdings Inc. has a trailing P/E of 33.57× based on publicly available market data.
Does IQV pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is IQV in?
IQVIA Holdings Inc. is classified in Healthcare (Diagnostics & Research) on NYQ.
What is IQV's market capitalization?
Approximate market cap: $44.09B.
What are the main risks for IQV?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of IQV?
Potential positives include revenue growth of 8.7% year-over-year, return on equity near 22.8% — efficient use of shareholder capital.
Where can I get analyst estimates for IQV?
Public analyst price targets and consensus for IQVIA Holdings Inc. are on the free /stocks/iqv/estimates page. Deeper estimate history and models are available in Vest Terminal.